Eli Lilly and Co/ US5324571083 /
24/05/2024 21:59:56 | Chg. -1.10 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
806.74USD | -0.14% | 43,587 Turnover: 35.25 mill. |
-Bid Size: - | -Ask Size: - | 767.39 bill.USD | 0.58% | 138.73 |
GlobeNewswire
24/05
Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
GlobeNewswire
16/05
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire
16/05
Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire
13/05
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
13/05
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire
08/05
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
08/05
Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire
01/05
H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire
30/04
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
30/04
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
29/04
Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...
GlobeNewswire
26/04
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...
GlobeNewswire
22/04
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
GlobeNewswire
22/04
TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology...
GlobeNewswire
17/04
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors